Dietary Supplement Hymecromone and Sorafenib: A Novel Combination for the Control of Renal Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dietary Supplement Hymecromone and Sorafenib: A Novel Combination for the Control of Renal Cell Carcinoma

Published:2013-07 Issue:1 Volume:190 Page:285-290
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Benitez Anaid¹,Yates Travis J.¹,Shamaldevi N.²,Bowen Tim³,Lokeshwar Vinata B.¹²⁴

Affiliation:

1. Sylvester Comprehensive Cancer Center, University of Miami-Miller School of Medicine, Miami, Florida

2. Department of Urology, University of Miami-Miller School of Medicine, Miami, Florida

3. Section of Nephrology, Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, United Kingdom

4. Department of Cell Biology, University of Miami-Miller School of Medicine, Miami, Florida

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference28 articles.

1. Evaluation and management of the renal mass;Chen;Med Clin North Am,2011

2. Defining an individualized treatment strategy for metastatic renal cancer;Hu;Urol Clin North Am,2012

3. Integration of surgery and systemic therapy for renal cell carcinoma;Kenney;Urol Clin North Am,2012

4. Sorafenib in renal cell carcinoma;Arranz;Crit Rev Oncol Hematol,2011

5. Sorafenib for the management of advanced renal cell carcinoma;Escudier;Expert Rev Anticancer Ther,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heterocycles fused on a 6,7-coumarin framework: an in-depth review of their structural and pharmacological diversity;Chemical Papers;2024-07-31

2. Glycooligomer-Functionalized Catalytic Nanocompartments Co-Loaded with Enzymes Support Parallel Reactions and Promote Cell Internalization;Biomacromolecules;2024-06-24

3. 4-Chloroskimmetine-based derivatives as potential anticancer and antibacterial prospects: Their synthesis and in vitro inspections;Results in Chemistry;2024-01

4. Kidney Cancer Integrative Oncology: Possible Options for Care;Current Oncology Reports;2023-07-19

5. Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma;Cancer Cell International;2022-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3